Recombinant Human Anti-FN1 x Human Anti-HSG Bispecific Antibody (Diabody-CH3) (BSDBC-H329)

Recombinant Anti-FN1 x Anti-HSG Bispecific Antibody (Diabody-CH3) is a fusion protein of two diabodies connected together by a CH3 region. In a diabody, the two scFvs with short linkers are from anti-FN1 and anti-HSG antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to each of the CH3 chains, which results in 2+2 antigen-binding valency and extends the half-life of this BsAb. This BsAb can be used in pretargeting system of PET, radioimaging or radiotherapy. It can mediate targeting of radioactivity to tumor cells. It is designed for the research of Solid tumors imaging and therapy.

Datasheet INQUIRY

Specifications

Targets

FN1 & HSG

Type

Constant Domain-extended Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Pretargeting system for radioimaging and radiotherapy

Related Disease

Solid tumors

Targets

Target 1

FN1

Gene ID

2335

UniProt ID

P02751

Alternative Names

FN1; fibronectin 1; FN; CIG; FNZ; MSF; ED-B; FINC; GFND; LETS; GFND2; Cold-insoluble globulin; Migration-stimulating factor

Target 2

HSG

Alternative Names

histaminyl-succinyl-glycine; HSG

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-FN1 x Human Anti-HSG Bispecific Antibody (Diabody-CH3) (BSDBC-H329). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-FN1 x Human Anti-HSG Bispecific Antibody (Diabody-CH3) (CAT#: BSDBC-H329)

Specifications

Targets

Customer Reviews and Q&As